Privitera, G., Pugliese, D., Scaldaferri, F., & Armuzzi, A. (2021). Letter: SARS‐CoV‐2 infection in two IBD patients treated with dual targeted therapy. Alimentary Pharmacology & Therapeutics, 53(6), 764. https://doi.org/10.1111/apt.16271
Chicago Style (17th ed.) CitationPrivitera, Giuseppe, Daniela Pugliese, Franco Scaldaferri, and Alessandro Armuzzi. "Letter: SARS‐CoV‐2 Infection in Two IBD Patients Treated with Dual Targeted Therapy." Alimentary Pharmacology & Therapeutics 53, no. 6 (2021): 764. https://doi.org/10.1111/apt.16271.
MLA (9th ed.) CitationPrivitera, Giuseppe, et al. "Letter: SARS‐CoV‐2 Infection in Two IBD Patients Treated with Dual Targeted Therapy." Alimentary Pharmacology & Therapeutics, vol. 53, no. 6, 2021, p. 764, https://doi.org/10.1111/apt.16271.